Study findings suggest that approximately one-third of patients with rheumatoid arthritis have long-term unacceptable pain, despite control of inflammation in the majority of these people.
UK research suggests there is a disparity between humoral and cellular immune responses to the first dose of the Pfizer–BioNTech COVID-19 vaccine in people on methotrexate monotherapy for psoriasis.
Study findings suggest that approximately one-third of patients with rheumatoid arthritis have long-term unacceptable pain, despite control of inflammation in the majority of these people.
Findings from two real-world studies presented at the EULAR 2021 Virtual Congress suggest that JAK inhibitors and biologics are similarly effective for the treatment of inflammatory arthritis.
The addition of dapirolizumab pegol to standard therapy may warrant further investigation for the treatment of systemic lupus erythematosus, phase 2 trial results suggest.
